MegaChips Corporation (6875):企業の財務・戦略的SWOT分析

◆英語タイトル:MegaChips Corporation (6875) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C2559
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:技術・通信
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

MegaChips Corporation (6875) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

MegaChips Corporation (MegaChips) is a fabless semiconductor company. Its product portfolio comprises application specific standard products (ASSPs) and application-specific integrated circuits (ASICs). The company integrates technologies and intellectual property in the areas of analog, digital and MEMS technologies to treat customer pain points. MegaChips’ products find application in storing game software; digital cameras image processing; smartphones and wearables; displays; TVs; and video devices; and communications for industrial applications. The company also develops large scale integrated (LSI) solutions. The company has business presence in China, Taiwan, the US, and India. It has offices in Tokyo and Makuhari. MegaChips is headquartered in Osaka, Japan.

MegaChips Corporation Key Recent Developments

Feb 02,2017: MegaChips reports higher nine-month loss, provides annual forecast

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
MegaChips Corporation – Key Facts 5
MegaChips Corporation – Key Employees 6
MegaChips Corporation – Key Employee Biographies 7
MegaChips Corporation – Major Products and Services 8
MegaChips Corporation – History 9
MegaChips Corporation – Company Statement 11
MegaChips Corporation – Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2 – Company Analysis 14
Company Overview 14
MegaChips Corporation – Business Description 15
MegaChips Corporation – SWOT Analysis 16
SWOT Analysis – Overview 16
MegaChips Corporation – Strengths 16
MegaChips Corporation – Weaknesses 17
MegaChips Corporation – Opportunities 18
MegaChips Corporation – Threats 19
MegaChips Corporation – Key Competitors 20
Section 3 – Company Financial Ratios 21
Financial Ratios – Capital Market Ratios 21
Financial Ratios – Annual Ratios 22
Performance Chart 25
Financial Performance 25
Financial Ratios – Interim Ratios 26
Financial Ratios – Ratio Charts 27
Section 4 – Company’s Recent Developments 28
Feb 02, 2017: MegaChips reports higher nine-month loss, provides annual forecast 28
Section 5 – Appendix 29
Methodology 29
Ratio Definitions 29
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
MegaChips Corporation, Key Facts 5
MegaChips Corporation, Key Employees 6
MegaChips Corporation, Key Employee Biographies 7
MegaChips Corporation, Major Products and Services 8
MegaChips Corporation, History 9
MegaChips Corporation, Other Locations 12
MegaChips Corporation, Subsidiaries 12
MegaChips Corporation, Key Competitors 20
MegaChips Corporation, Ratios based on current share price 21
MegaChips Corporation, Annual Ratios 22
MegaChips Corporation, Annual Ratios (Cont...1) 23
MegaChips Corporation, Annual Ratios (Cont...2) 24
MegaChips Corporation, Interim Ratios 26
Currency Codes 29
Capital Market Ratios 29
Equity Ratios 30
Profitability Ratios 30
Cost Ratios 31
Liquidity Ratios 31
Leverage Ratios 32
Efficiency Ratios 32

List of Figures
MegaChips Corporation, Performance Chart (2014 - 2018) 25
MegaChips Corporation, Ratio Charts 27

★海外企業調査レポート[MegaChips Corporation (6875):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Chubu Electric Power Co Inc (9502):電力:M&Aディール及び事業提携情報
    Summary Chubu Electric Power Co Inc (Chubu) is an energy utility. It generates and procures electricity; and offers electric network related services. The company produces electricity using hydro, thermal, nuclear and renewable sources. Chubu has interests in upstream and midstream energy fields. It …
  • Mendor Oy-製薬・医療分野:企業M&A・提携分析
    Summary Mendor Oy (Mendor) is a medical equipment company that designs, develops and markets advanced diabetes management products. The company’s products include portable blood glucose meter and web-based software application for the daily management of diabetes. It offers blood glucose meter mendo …
  • Nymox Pharmaceutical Corp (NYMX):製薬・医療:M&Aディール及び事業提携情報
    Summary Nymox Pharmaceutical Corp (Nymox) is a biopharmaceutical company that undertakes the research and development of therapeutics and diagnostics devices to target the unmet needs of the aging population. The company markets diagnostic products for measuring tobacco product exposure and for the …
  • Dan Hotels Corporation Ltd:戦略・SWOT・企業財務分析
    Dan Hotels Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary Dan Hotels Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Avenue Therapeutics Inc (ATXI):製薬・医療:M&Aディール及び事業提携情報
    Summary Avenue Therapeutics Inc (Avenue Therapeutics), a subsidiary of Fortress Biotech Inc, is a specialty pharmaceutical company that focuses on the development and commercialization of an intravenous (IV) tramadol for the management of severe postoperative pain in adults. The company’s IV Tramado …
  • Hindustan Unilever Ltd (HINDUNILVR):企業の財務・戦略的SWOT分析
    Hindustan Unilever Ltd (HINDUNILVR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Acer Incorporated:企業の戦略・SWOT・財務情報
    Acer Incorporated - Strategy, SWOT and Corporate Finance Report Summary Acer Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Westinghouse Electric Company LLC-エネルギー分野:企業M&A・提携分析
    Summary Westinghouse Electric Company, LLC (Westinghouse), a subsidiary of Toshiba Corporation, is a nuclear energy company. It offers nuclear plant products, technologies, nuclear fuel, plant design and related services to utilities across the world. The company conducts the development, licensing, …
  • Camurus AB (CAMX):企業の財務・戦略的SWOT分析
    Summary Camurus AB (Camurus), a subsidiary of Sandberg Development AB, is a pharmaceutical company that carries out development and commercialization of treatments for the patients suffering from chronic diseases. The company’s technology includes smart and versatile drug delivery, injection depot, …
  • Liechtensteinische Landesbank Private Clients:企業の戦略・SWOT・財務情報
    Liechtensteinische Landesbank Private Clients - Strategy, SWOT and Corporate Finance Report Summary Liechtensteinische Landesbank Private Clients - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • Western Areas Limited:企業の戦略・SWOT・財務情報
    Western Areas Limited - Strategy, SWOT and Corporate Finance Report Summary Western Areas Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • AeroParts Manufacturing & Repair, Inc:企業の戦略・SWOT・財務情報
    AeroParts Manufacturing & Repair, Inc - Strategy, SWOT and Corporate Finance Report Summary AeroParts Manufacturing & Repair, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Celanese Corp (CE):企業の財務・戦略的SWOT分析
    Celanese Corp (CE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Vail Resorts Inc:戦略・SWOT・企業財務分析
    Vail Resorts Inc - Strategy, SWOT and Corporate Finance Report Summary Vail Resorts Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Public Establishment for Electricity Generation and Transmission Co:企業の戦略的SWOT分析
    Public Establishment for Electricity Generation and Transmission Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key empl …
  • OcuNexus Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary OcuNexus Therapeutics Inc (OcuNexus Therapeutics) is a development stage biopharmaceutical company engaged in novel therapeutics for unmet clinical needs in ophthalmology. It has highly differentiated, lead drug candidates based upon a novel mechanism of action such as Gap Junction Channel M …
  • AeroControlex Group Inc.:企業の戦略・SWOT・財務情報
    AeroControlex Group Inc. - Strategy, SWOT and Corporate Finance Report Summary AeroControlex Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • ReWalk Robotics Ltd (RWLK):医療機器:M&Aディール及び事業提携情報
    Summary ReWalk Robotics Ltd (ReWalk) is a medical device company that designs, develops and commercializes exoskeletons. The company provides walk restoration devices for people with lower limb disabilities to stand and walk once again. Its products include ReWalk personal system and ReWalk rehabili …
  • Charles River Laboratories International Inc (CRL):医療機器:M&Aディール及び事業提携情報
    Summary Charles River Laboratories International Inc (Charles River) is a contract research organization (CRO) that provides essential products and services to accelerate the research, drug discovery and development. It offers various basic research, drug discovery and safety assessment services. Th …
  • Biomay AG-製薬・医療分野:企業M&A・提携分析
    Summary Biomay AG (Biomay) discovers and develops disease modifying allergy therapeutics. The company develops peptide carrier fusion vaccines for allergy immunotherapy. Its pipeline product portfolio comprises investigation candidates targeted against IgE mediated diseases, grass pollen allergy, ho …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆